SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will present data from a 24-week subgroup analysis of its ongoing Phase 2 SOLSTICE trial in chronic hepatitis delta at the upcoming European Association for the Study of the Liver (EASL) Congress 2025 in Amsterdam (The Netherlands), May 7-10. The Company will also present 24 Week post-treatment follow-up data from the MARCH Phase 2 clinical study evaluating combinations of tobevibart and elebsiran,.

ROCKVILLE, Md. , April 24, 2025 /PRNewswire/ -- Xiao-I Corporation (NASDAQ: AIXI), a global leader in artificial intelligence solutions, today announced accelerated commercial traction for its AI-powered glasses, with its dedicated AI Glasses business unit on track to generate between $12 million and $15 million in revenue in 2025.

NEW YORK, NY / ACCESS Newswire / April 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Uber Technologies, Inc. ("Uber") (NYSE:UBER) concerning possible violations of federal securities laws. The Federal Trade Commission ("FTC") filed a lawsuit against Uber on April 21, 2025.

NEW YORK, NY / ACCESS Newswire / April 24, 2025 / If you suffered a loss on your Rocket Lab USA, Inc. (NASDAQ:RKLB) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rocket-lab-usa-inc-lawsuit-submission-form?prid=144908&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / April 24, 2025 / If you suffered a loss on your Canopy Growth Corporation (NASDAQ:CGC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/canopy-growth-corporation-lawsuit-submission-form?prid=144911&wire=1 or contact Joseph E. Levi, Esq.

CHICAGO , April 24, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced plans to launch XRP futures on May 19, pending regulatory review. Market participants will have the choice to trade both a micro-sized contract (2,500 XRP) and a larger-sized contract (50,000 XRP).

POTOMAC, MARYLAND / ACCESS Newswire / April 24, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company") today announced that the Company's recently appointed advisors entered into a Share Purchase Agreement (the "SPA") on April 21, 2025, for the purchase of common shares from the Company. The investment, subject to the terms and conditions set forth in the SPA, is for approximately $475 thousand at the higher of 30 cents or $0.01 over the last closing price.

Investors seeking to generate positive returns through the stock market turbulence should take a close look at Kroger (KR -1.42%). Shares of the grocery store giant are trading at an all-time high price, up 16% year to date, in sharp contrast to the 10% decline in the S&P 500 index over the period.

NEW YORK, NY / ACCESS Newswire / April 24, 2025 / If you suffered a loss on your NET Power, Inc. (NYSE:NPWR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/net-power-inc-lawsuit-submission-form?prid=144909&wire=1 or contact Joseph E. Levi, Esq.

SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements concerning Net Power business and prospects, resulting in its stock trading at inflated prices.

ZIBO, China, April 24, 2025 (GLOBE NEWSWIRE) -- Sunrise New Energy Co., Ltd. (“Sunrise”, the “Company”, “we” or “our”) (NASDAQ: EPOW), a leading innovator in battery materials, today announced that the company-led project titled “Research and Demonstration of Key Engineering Technologies for Long-Life, Low-Cost Sodium-Ion Battery Hard Carbon Anode Materials” has officially been approved by the Guizhou Provincial Department of Science and Technology following multiple rounds of expert panel reviews. The project has secured approximately $960,000 funding under a special science and technology grant.

SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Ibotta, Inc. (NYSE: IBTA) publicly traded securities pursuant and/or traceable to Ibotta's registration statement and related prospectus issued in connection with Ibotta's initial public offering (“IPO”) held on or around April 18, 2024, have until June 16, 2025 to seek appointment as lead plaintiff of the Ibotta class action lawsuit. Captioned Fortune v. Ibotta, Inc., No. 25-cv-01213 (D. Colo.), the Ibotta class action lawsuit charges Ibotta as well as certain of Ibotta's top executives and directors, as well as the …

Barton Crockett, Rosenblatt Securities senior analyst, joins 'Squawk Box' to preview Alphabet's quarterly earnings results, what to expect from the tech giant, and more.

We recommend five consulting stocks with a favorable Zacks Rank and strong near-term price upside to strengthen your portfolio. These are HURN, CBZ, STN, IIII, CRAI.

At this stage, it will be prudent to buy NFLX and hold for the long term as its strong execution of the last few quarters and robust future projections will generate more value.

UPST's AI-powered innovation, robust financial growth and expanding loan offerings position it well for future growth, making the stock worth holding.

NovoCure (NVCR 7.15%), a leader in oncology treatments using Tumor Treating Fields (TTFields) therapy, released its first-quarter results on April 24, 2025. The company reported notable gains with revenue rising to $155 million (GAAP) in Q1 2025, surpassing Wall Street's estimate of $146 million.

LOS ANGELES , April 24, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Bakkt Holdings, Inc. ("Bakkt" or "the Company") (NYSE: BKKT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between March 25, 2024 and March 17, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before June 2, 2025.

Manhattan Associates (MANH) presents a compelling long-term investment opportunity despite weak guidance and management transition concerns, with Q1 2025 results showing signs of stabilization. MANH's recurring revenue model and specialization in warehouse management and supply chain solutions provide a strong moat, making it resilient to macroeconomic fluctuations. Cloud revenue growth of 21% YoY in Q1 2025 indicates a strategic shift towards more stable, long-term contracts, offsetting declines in service revenues.

LOS ANGELES , April 24, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Everus Construction Group, Inc. ("Everus" or "the Company") (NYSE: ECG) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between October 31, 2024 and February 11, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before June 3, 2025.